1022983-70-5 Usage
Uses
Used in Organic Synthesis:
2-(4-ethylbenzyl)-4-bromo-6-methoxybenzonitrile is used as a building block in organic synthesis for the creation of various organic compounds due to its unique structure and functional groups.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(4-ethylbenzyl)-4-bromo-6-methoxybenzonitrile is used as an intermediate in the synthesis of pharmaceuticals, leveraging its chemical properties to contribute to the development of new drugs.
Used in Materials Science:
2-(4-ethylbenzyl)-4-bromo-6-methoxybenzonitrile may be utilized in materials science for the development of new materials, given its potential to form novel compounds with specific properties.
(Note: The specific applications and reasons for the use of 2-(4-ethylbenzyl)-4-bromo-6-methoxybenzonitrile in various industries would need to be confirmed through experimental research and development, as the provided materials do not detail specific uses beyond its role as a building block in synthesis and potential applications in materials science.)
Check Digit Verification of cas no
The CAS Registry Mumber 1022983-70-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,9,8 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1022983-70:
(9*1)+(8*0)+(7*2)+(6*2)+(5*9)+(4*8)+(3*3)+(2*7)+(1*0)=135
135 % 10 = 5
So 1022983-70-5 is a valid CAS Registry Number.
1022983-70-5Relevant academic research and scientific papers
PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE
-
, (2022/01/26)
The invention relates to a pharmaceutical composition according to the claim 1 comprising a glucopyranosyl-substituted benzene derivative in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZONITRILE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
-
Page/Page column 44, (2008/12/05)
Glucopyranosyl-substituted benzyl-benzonitrile derivatives of general formula (I) as defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
